引用本文
  •    [点击复制]
  •    [点击复制]
PDF HTML全文阅读
本文已被:浏览 2651次   下载 1290 本文二维码信息
码上扫一扫!
参苓白术散合四神丸联合化疗治疗结直肠癌根治术后的疗效观察
张漪,戴涵斌,朱沛枫
浙江省湖州市第一人民医院药剂科浙江湖州 31300;浙江省湖州市第一人民医院普外科浙江湖州 31300
摘要:
目的:探讨参苓白术散合四神丸联合化疗治疗结直肠癌根治术后的疗效。方法:通过随机抽样法将2016年1月—2019年12月期间在我院行结直肠癌根治术的100例患者分为对照组与研究组,术后分别给予化疗治疗、参苓白术散合四神丸联合化疗治疗,对比患者近期疗效、中医证候评分、肿瘤标志物、免疫功能指标水平、不良反应现象等。结果:两组患者治疗前肿瘤标志物、免疫功能指标水平差异不明显(P>0.05),治疗后研究组患者肿瘤标志物CEA水平低于对照组,免疫功能指标CD8+、CD4+/CD8+水平低于对照组,而CD4+水平高于对照组(P<0.05);研究组近期疗效评价48(96.0%)高于对照组32(64.0%),差异具有统计学意义(P<0.05)。研究组患者不良反现象2(4.0%)少于对照组12(24.0%),差异具有统计学意义(P<0.05)。研究组恶心呕吐中医症状评分(0.24±0.15)、腹痛腹胀(0.21±0.15)、疲倦乏力(0.20±0.10)、腰酸膝疼(0.19±0.08)、畏寒肢冷(0.17±0.11)均低于对照组恶心呕吐中医症状评分(1.20±0.49)、腹痛腹胀(0.98±0.67)、疲倦乏力(1.00±0.65)、腰酸膝疼(0.88±0.62)、畏寒肢冷(0.87±0.60)差异具有统计学意义(t=2.331、2.002、1.985、1.672、1.354,P<0.05)。结论:结直肠癌根治术患者,手术后接受参苓白术散合四神丸联合化疗治疗,可有效减轻化疗不良反应,改善免疫功能,安全可靠,近期疗效理想。
关键词:  结直肠癌  参苓白术散合四神丸  联合化疗
DOI:10.3969/j.issn.1007-6948.2021.04.009
投稿时间:2020-08-15
基金项目:
Observation on the Curative Effect of Shenling Baizhu Powder and Sishen Pill Combined with Chemotherapy for Radical Resection of Colorectal Cancer
ZHANG Yi,DAI Han-bin,ZHU Pei-feng
Pharmacy Department,The first people' s Hospital of Huzhou City, Zhejiang Province ,Zhejiang (31300), China
Abstract:
Objective To investigate the curative effect of Shenling Baizhu Powder and Sishen Pill combined with chemotherapy for radical resection of colorectal cancer. Methods By random sampling method, 100 patients in our hospital from January 2016 to December 2019 were divided into control group and colorectal cancer radical group. They were given chemotherapy after surgery, Shenling Baizhu Powder and Sishen Pill combined with chemotherapy treatment respectively. The curative effect of the patients in the near future, TCM syndrome score, tumor markers, immune function index levels and adverse phenomenon were compared. Results There were no significant differences in tumor markers and immune function indexes between the two groups before treatment (P>0.05). After treatment, CEA level of tumor markers in the study group was lower than that in the control group. The CD8+ and CD4+ were lower than those in the control group, while CD4+ was higher than that in the control group (P<0.05). The short-term efficacy evaluation of the study group was 48 (96.00%), which was higher than that of the control group 32 (64.00%) and the difference was statistically significant (P<0.05). Adverse reaction of patients in the study group 2 (4.00%) was less than that in the control group 12 (24.00%), and the difference was statistically significant (P<0.05). The nausea and vomiting of TCM symptom scores (0.24±0.15), abdominal pain and abdominal distension (0.21 ± 0.15), tired weak (0.20 ±0.10), knee pain and waist acid (0.19 ± 0.08), cold and cold limbs (0.17 ± 0.11) were lower than those of the control group, which the nausea and vomiting of TCM symptom scores (1.20±0.49), abdominal pain and abdominal distension (0.98±0.67), tired weak (1.00±0.65), knee pain and waist acid (0.88±0.62), cold and cold limbs (0.87±0.60). The differences are statistically significant (t=2.331, 2.002, 1.985, 1.672, 1.354; P<0.05). Conclusion For patients undergoing radical resection of colorectal cancer, Shenling Baizhu Powder and Sishen Pill combined with chemotherapy after surgery can effectively reduce the toxic and side effects of chemotherapy, improve immune function. They are safe and reliable, which have ideal short-term ef?cacy. This
Key words:  Colorectal cancer  Shenling Baizhu powder combined with Sishen pills  combined chemotherapy

用微信扫一扫

用微信扫一扫